A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol

BACKGROUND: Recent evidence underscores the utility of rapid-acting antidepressant interventions, such as ketamine, in alleviating symptoms of major depressive episodes (MDE). However, to date, there have been limited head-to-head comparisons of intravenous (IV) ketamine infusions with other antidep...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Jennifer L., Jaworska, Natalia, Kamler, Elizabeth, Bhat, Venkat, Blier, Jean, Foster, Jane A., Hassel, Stefanie, Ho, Keith, McMurray, Lisa, Milev, Roumen, Moazamigoudarzi, Zahra, Placenza, Franca M., Richard-Devantoy, Stéphane, Rotzinger, Susan, Turecki, Gustavo, Vazquez, Gustavo H., Kennedy, Sidney H., Blier, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265624/
https://www.ncbi.nlm.nih.gov/pubmed/32487236
http://dx.doi.org/10.1186/s12888-020-02672-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265624/
https://www.ncbi.nlm.nih.gov/pubmed/32487236
http://dx.doi.org/10.1186/s12888-020-02672-3

Ejemplares similares